Hennion & Walsh Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.2M Buy
14,360
+35
+0.2% +$35.8K 0.49% 34
2026
Q1
$13.2M Buy
14,325
+270
+2% +$274K 0.44% 36
2025
Q4
$15.1M Sell
14,055
-430
-3% -$411K 0.52% 31
2025
Q3
$11.1M Sell
14,485
-525
-3% -$391K 0.4% 38
2025
Q2
$11.7M Buy
15,010
+927
+7% +$720K 0.47% 32
2025
Q1
$11.6M Sell
14,083
-835
-6% -$695K 0.52% 29
2024
Q4
$11.5M Buy
14,918
+451
+3% +$373K 0.52% 32
2024
Q3
$12.8M Sell
14,467
-5,432
-27% -$4.88M 0.6% 25
2024
Q2
$18M Sell
19,899
-767
-4% -$614K 0.93% 13
2024
Q1
$16.1M Sell
20,666
-4,130
-17% -$2.94M 0.86% 11
2023
Q4
$14.5M Sell
24,796
-2,128
-8% -$1.24M 0.83% 14
2023
Q3
$14.5M Sell
26,924
-4,239
-14% -$2.18M 0.92% 13
2023
Q2
$14.6M Buy
31,163
+2,315
+8% +$971K 0.87% 15
2023
Q1
$9.91M Sell
28,848
-2,118
-7% -$714K 0.61% 23
2022
Q4
$11.3M Sell
30,966
-859
-3% -$305K 0.7% 20
2022
Q3
$10.3M Sell
31,825
-5,654
-15% -$1.79M 0.68% 24
2022
Q2
$12.2M Sell
37,479
-5,006
-12% -$1.5M 0.75% 21
2022
Q1
$12.2M Buy
42,485
+2,356
+6% +$606K 0.65% 29
2021
Q4
$11.1M Sell
40,129
-93
-0.2% -$23.6K 0.54% 38
2021
Q3
$9.29M Buy
40,222
+5,792
+17% +$1.43M 0.49% 45
2021
Q2
$7.9M Buy
34,430
+2,524
+8% +$507K 0.42% 46
2021
Q1
$5.96M Buy
+31,906
New +$6.24M 0.36% 70

Other funds holding LLY

Hennion & Walsh Asset Management's LLY Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its Eli Lilly (LLY) stake by 0.24% in Q2 2026, buying an estimated $35.8K and bringing the position to 14,360 shares worth $17.2M. The position accounts for 0.49% of the portfolio, ranked #34.

Hennion & Walsh Asset Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $18M in Q2 2024. 1,549 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hennion & Walsh Asset Management held 14,360 shares of Eli Lilly worth $17.2M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 35 Eli Lilly shares in Q2 2026, an estimated $35.8K.
  • Eli Lilly made up 0.49% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #34 holding.
  • Hennion & Walsh Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's Eli Lilly position peaked at $18M in Q2 2024.
  • 1,549 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.